The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
Open accessAbstract
Background: Musculoskeletal disorders include more than 150 different conditions affecting joints, muscles, bones, ligaments, tendons, and the spine. To capture all health loss from death and disability due to musculoskeletal disorders, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) includes a residual musculoskeletal category for conditions other than osteoarthritis, rheumatoid arthritis, gout, low back pain, and neck pain. This category is called other musculoskeletal disorders and includes, for example, systemic lupus erythematosus and spondylopathies. We provide updated estimates of the prevalence, mortality, and disability attributable to other musculoskeletal disorders and forecasted prevalence to 2050. Methods: Prevalence of other musculoskeletal disorders was estimated in 204 countries and territories from 1990 to 2020 using data from 68 sources across 23 countries from which subtraction of cases of rheumatoid arthritis, osteoarthritis, low back pain, neck pain, and gout from the total number of cases of musculoskeletal disorders was possible. Data were analysed with Bayesian meta-regression models to estimate prevalence by year, age, sex, and location. Years lived with disability (YLDs) were estimated from prevalence and disability weights. Mortality attributed to other musculoskeletal disorders was estimated using vital registration data. Prevalence was forecast to 2050 by regressing prevalence estimates from 1990 to 2020 with Socio-demographic Index as a predictor, then multiplying by population forecasts. Findings: Globally, 494 million (95% uncertainty interval 431-564) people had other musculoskeletal disorders in 2020, an increase of 123·4% (116·9-129·3) in total cases from 221 million (192-253) in 1990. Cases of other musculoskeletal disorders are projected to increase by 115% (107-124) from 2020 to 2050, to an estimated 1060 million (95% UI 964-1170) prevalent cases in 2050; most regions were projected to have at least a 50% increase in cases between 2020 and 2050. The global age-standardised prevalence of other musculoskeletal disorders was 47·4% (44·9-49·4) higher in females than in males and increased with age to a peak at 65-69 years in male and female sexes. In 2020, other musculoskeletal disorders was the sixth ranked cause of YLDs globally (42·7 million [29·4-60·0]) and was associated with 83 100 deaths (73 600-91 600). Interpretation: Other musculoskeletal disorders were responsible for a large number of global YLDs in 2020. Until individual conditions and risk factors are more explicitly quantified, policy responses to this burden remain a challenge. Temporal trends and geographical differences in estimates of non-fatal disease burden should not be overinterpreted as they are based on sparse, low-quality data. Funding: Bill & Melinda Gates Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Self-citationWARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Self-citationWang, H., Abbas, K. M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abolhassani, H., Abreu, L. G., Abrigo, M. R. M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30977-6 · Cited by 1,971
Self-citationGuidelines for accurate and transparent health estimates reporting: the GATHER statement
Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30388-9 · Cited by 1,798
Self-citationVollset, S. E., Goren, E., Yuan, C.-W., Cao, J., Smith, A. E., Hsiao, T., Bisignano, C., Azhar, G. S., Castro, E., Chalek, J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30677-2 · Cited by 1,506
Self-citationRees, F., Doherty, M., Grainge, M. J., Lanyon, P., & Zhang, W. (2017) · Rheumatology · doi:10.1093/rheumatology/kex260 · Cited by 789
Global prevalence of ankylosing spondylitis
Dean, L. E., Jones, G. T., MacDonald, A. G., Downham, C., Sturrock, R. D., & Macfarlane, G. J. (2014) · Rheumatology · doi:10.1093/rheumatology/ket387 · Cited by 722
The global burden of SLE: prevalence, health disparities and socioeconomic impact
Carter, E. E., Barr, S. G., & Clarke, A. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.137 · Cited by 497
Guidelines for accurate and transparent health estimates reporting: the GATHER statement
Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002056 · Cited by 424
Cited by
Brauer, M., Roth, G. A., Aravkin, A. Y., Zheng, P., Abate, K. H., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00933-4 · Cited by 2,884
Self-citationGonzález-Álvarez, M. E., Riquelme-Aguado, V., González-Pérez, Á., Murillo-Llergo, R., Manjón-Olmedillas, M., Turroni, S., Rossettini, G., & Villafañe, J. H. (2024) · Cells · doi:10.3390/cells13201719 · Cited by 20
Metadata
- Authors
- Gill, T. K., Mittinty, M. M., March, L. M., Steinmetz, J. D., Culbreth, G. T., Cross, M., Kopec, J. A., Woolf, A. D., Haile, L. M., Hagins, H., Ong, K. L., Kopansky-Giles, D. R., Dreinhoefer, K. E., Betteridge, N., Abbasian, M., Abbasifard, M., Abedi, K., Adesina, M. A., Aithala, J. P., Akbarzadeh-Khiavi, M., Al Thaher, Y., Alalwan, T. A., Alzahrani, H., Amiri, S., Antony, B., Arabloo, J., Aravkin, A. Y., Arumugam, A., Aryal, K. K., Athari, S. S., Atreya, A., Baghdadi, S., Bardhan, M., Barrero, L. H., Bearne, L. M., Bekele, A. B., Bensenor, I. M., Bhardwaj, P., Bhatti, R., Bijani, A., Bordianu, T., Bouaoud, S., Briggs, A. M., Cheema, H. A., Christensen, S. W. M., Chukwu, I. S., Clarsen, B., Dai, X., de Luca, K., Desye, B., Dhimal, M., Do, T. C., Fagbamigbe, A. F., Farokh Forghani, S., Ferreira, N., Ganesan, B., Gebrehiwot, M., Ghashghaee, A., Graham, S. M., Harlianto, N. I., Hartvigsen, J., Hasaballah, A. I., Hasanian, M., Hassen, M. B., Hay, S. I., Heidari, M., Hsiao, A. K., Ilic, I. M., Jokar, M., Khajuria, H., Khan, M. J., Khanal, P., Khateri, S., Kiadaliri, A., Kim, M. S., Kisa, A., Kolahi, A.-A., Krishan, K., Krishnamoorthy, V., Landires, I., Larijani, B., Le, T. T. T., Lee, Y. H., Lim, S. S., Lo, J., Madani, S. P., Malagón-Rojas, J. N., Malik, I., Marateb, H. R., Mathew, A. J., Meretoja, T. J., Mesregah, M. K., Mestrovic, T., Mirahmadi, A., Misganaw, A., Mohaghegh, S., Mokdad, A. H., Momenzadeh, K., Momtazmanesh, S., Monasta, L., Moni, M. A., Moradi, Y., Mostafavi, E., Muhammad, J. S., Murray, C. J. L., Muthu, S., Nargus, S., Nassereldine, H., Neupane, S., Niazi, R. K., Oh, I.-H., Okati-Aliabad, H., Oulhaj, A., Pacheco-Barrios, K., Park, S., Patel, J., Pawar, S., Pedersini, P., Peres, M. F. P., Petcu, I.-R., Petermann-Rocha, F. E., Poursadeqiyan, M., Qattea, I., Qureshi, M. F., Rafferty, Q., Rahimi-Dehgolan, S., Rahman, M., Ramasamy, S. K., Rashedi, V., Redwan, E. M. M., Ribeiro, D. C., Roever, L., Safary, A., Sagoe, D., Saheb Sharif-Askari, F., Sahebkar, A., Salehi, S., Shafaat, A., Shahabi, S., Sharma, S., Shashamo, B. B., Shiri, R., Singh, A., Slater, H., Smith, A. E., Sunuwar, D. R., Tabish, M., Tharwat, S., Ullah, I., Valadan Tahbaz, S., Vasankari, T. J., Villafañe, J. H., Vollset, S. E., Wiangkham, T., Yonemoto, N., You, Y., Zare, I., Zheng, P., Vos, T., & Brooks, P. M.
- Venue
- The Lancet Rheumatology
- Publisher
- Elsevier BV
- Published
- 2023-11
- Volume
- 5
- Issue
- 11
- Pages
- e670-e682
- ISSN
- 2665-9913 (ISSN-L)
- OpenAlex
- W4387890132
- Cited by
- 422
- References
- 20
- FWCI
- 54.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. https://app.cochat.ai/papers/10.1016/s2665-9913(23)00232-1
- The paper
- Gill, T. K., Mittinty, M. M., March, L. M., Steinmetz, J. D., Culbreth, G. T., Cross, M., Kopec, J. A., Woolf, A. D., Haile, L. M., Hagins, H., Ong, K. L., Kopansky-Giles, D. R., Dreinhoefer, K. E., Betteridge, N., Abbasian, M., Abbasifard, M., Abedi, K., Adesina, M. A., Aithala, J. P., . . . Brooks, P. M. (2023). Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Rheumatology. https://doi.org/10.1016/s2665-9913(23)00232-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.